| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.056 | 0.2 |